LabCorp
The computed 12-month bankruptcy probability of LabCorp is 0.4% (very low). The company has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 27 yrs |
| Locations | 2 |
| Publications | 16 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 29-05-2026 | 2026-00133176 |
| 31-12-2024 | volledig | 24-06-2025 | 2025-00177927 |
| 31-12-2023 | volledig | 15-05-2024 | 2024-00088235 |
| 31-12-2022 | volledig | 14-07-2023 | 2023-00242493 |
| 31-12-2021 | volledig | 16-12-2022 | 2022-20538806 |
| 31-12-2020 | volledig | 09-11-2021 | 2021-76900377 |
| 31-12-2019 | volledig | 13-11-2020 | 2020-70300375 |
| 31-12-2018 | volledig | 06-02-2020 | 2020-04800077 |
| 31-12-2017 | volledig | 31-12-2018 | 2018-75900226 |
| 31-12-2016 | volledig | 27-07-2017 | 2017-35900146 |
| NACE primary | 72109 |
| Legal form | Private limited company(610) |
| Incorporation | 12-03-1999 |
| Status | Active |
| Postal code | 2800 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12402A0053/00F000 | Flanders | 3.5 ha | 1 · 1.9 ha | 11.7 m · 3 fl. |
| 12402A0174/00N000 | Flanders | 1.0 ha | 1 · 4,081 m² | 11.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-04-2025 2 directors appointed, 2 resigning
- Robert Hainsworth, Bestuurder
- Kathryn Kyle, Bestuurder
- Glenn Eisenberg, Bestuurder
- Sandra van der Vaart, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Glenn Eisenberg",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sandra van der Vaart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert Hainsworth",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Kathryn Kyle",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}13-06-2024 DSD Associates Audit & Advies BV appointed as statutory auditor
- DSD Associates Audit & Advies BV, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "DSD Associates Audit \u0026 Advies BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}11-03-2024 Thomas J. KREMER appointed as director
- Thomas J. KREMER, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thomas J. KREMER",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}31-01-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}22-11-2021 DSD Associates Audit & Advies appointed as statutory auditor
- DSD Associates Audit & Advies, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "DSD Associates Audit \u0026 Advies",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}23-07-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
},
"legal_form_change": {
"new": "Besloten vennootschap",
"old": "Besloten vennootschap met beperkte aansprakelijkheid",
"changed": false
}
}26-02-2021 1 director appointed, 1 resigning
- Glen A. Eisenberg, Bestuurder
- Glen A. Eisenberg, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Glen A. Eisenberg",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Glen A. Eisenberg",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}04-06-2020 Laura Bello Castro appointed as volmachtdrager
- Laura Bello Castro, Volmachtdrager
Technical details
{
"events": [
{
"kind": "director_in",
"role": "Volmachtdrager",
"person": {
"rrn": null,
"name": "Laura Bello Castro",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}28-02-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
},
"legal_form_change": {
"new": "Besloten vennootschap met beperkte aansprakelijkheid",
"old": "Besloten vennootschap met beperkte aansprakelijkheid",
"changed": false
}
}31-07-2019 1 director appointed, 1 resigning
- Sandra van der Vaart, Zaakvoerder
- Floyd Samuel Eberts IIl, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Floyd Samuel Eberts IIl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Sandra van der Vaart",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}14-07-2017 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
},
"legal_form_change": {
"new": "Besloten vennootschap met beperkte aansprakelijkheid",
"old": "Besloten vennootschap met beperkte aansprakelijkheid",
"changed": false
}
}19-04-2017 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Michiel Dewael",
"firm_city": null,
"firm_name": null,
"office_city": "Mechelen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2017-04-19",
"filing_date": "2017-04-05",
"act_kind_objet": "Wijziging handelsnaam"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2017-03-06",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0465.578.521",
"name": "LabCorp",
"role": "other",
"address": "Generaal De Wittelaan, L11 A, 2800 Mechelen",
"is_foreign": false,
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "De wijziging betreft uitsluitend de handelsnaam van de vennootschap. Geen overdracht van vermogen of activa vindt plaats.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Michiel Dewael",
"org_rep_person_name": null
},
"summary_narrative": "Op 6 maart 2017 heeft de enige vennoot van LabCorp besloten de handelsnaam van de vennootschap te wijzigen van \u0027LabCorp Clinical Trials\u0027 naar \u0027Covance\u0027. De beslissing werd gepubliceerd in de Bijlagen bij het Belgisch Staatsblad op 19 april 2017. Bijzondere volmacht werd verleend aan Michiel Dewael, Klaus Heinemann, Michel Raats en het advocatenkantoor Marx Van Ranst Vermeersch \u0026 Partners om de publicatie en registratieformaliteiten te voltooien.",
"co_filed_documents": [],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}12-10-2015 1 director appointed, 1 resigning
- Ilse Mathieu, Bijzondere volmacht
- Marleen Hereygers, Bijzondere volmacht
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bijzondere volmacht",
"person": {
"rrn": null,
"name": "Marleen Hereygers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bijzondere volmacht",
"person": {
"rrn": null,
"name": "Ilse Mathieu",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}15-06-2015 Willy Goyvaerts appointed as statutory auditor
- Willy Goyvaerts, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Willy Goyvaerts",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}20-08-2007 1 director appointed, 1 resigning
- Kurt Peeters, Special mandate holder
- Richard Myers, Special mandate holder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "special mandate holder",
"person": {
"rrn": null,
"name": "Richard Myers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "special mandate holder",
"person": {
"rrn": null,
"name": "Kurt Peeters",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "ESOTERIX CLINICAL TRIALS SERVICES"
}
}23-02-2004 Capital increase of €7,000,000 to €19,000,000
- €12.000.000 → €19.000.000
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19000000,
"delta_eur": 7000000,
"before_eur": 12000000,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0465.578.521",
"name_full": "LabCorp"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | LabCorp |